About Japanese Red Cross Asahikawa Hospital
Clinical Trials at Japanese Red Cross Asahikawa Hospital
During the past decade, Japanese Red Cross Asahikawa Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Japanese Red Cross Asahikawa Hospital
According to Clinical.Site data, the most researched conditions in "Japanese Red Cross Asahikawa Hospital" are
"Migraine" (2 trials). Many other conditions were trialed in "Japanese Red Cross Asahikawa Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Japanese Red Cross Asahikawa Hospital
Most popular intervention types in "Japanese Red Cross Asahikawa Hospital" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Rimegepant" (1 trials), "Rimegepant 25 MG" (1 trials) and "Rimegepant 75 MG" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Japanese Red Cross Asahikawa Hospital
The vast majority of trials in "Japanese Red Cross Asahikawa Hospital" are
2 trials for "All" genders.
Clinical Trials Status at Japanese Red Cross Asahikawa Hospital
Currently, there are NaN active trials in "Japanese Red Cross Asahikawa Hospital".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Japanese Red Cross Asahikawa Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Japanese Red Cross Asahikawa Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".